大隐静脉交界不全行腔内热消融后3年复发类型的前瞻性队列研究
该前瞻性队列纳入449例首次因隐股交界不全接受腔内热消融的患者,3年随访显示临床相关复发率为5.1%,若将所有新发静脉曲张均计为复发则达约54%;新生血管为最常见复发类型,治疗静脉直径(P=.001)和CEAP临床分级(P=.008)是复发的显著预测因素。
要点
- 腔内热消融治疗隐股交界不全3年临床相关复发率低(5.1%)。
- 新生血管是最主要的复发类型,其次为再通和前副大隐静脉反流。
- 治疗静脉直径和CEAP临床分级是复发的显著预测因素。
核心结论
- 腔内热消融是治疗静脉曲张的有效方法,3年后复发率低。
- 提出面向实践的复发分类,区分技术失败、疾病进展和真正复发。
研究设计与样本
- 由三名经验丰富的静脉病学家实施治疗,两位经验丰富的静脉病学家通过超声进行复发分型。
主要发现
- 临床相关复发率为5.1%,仅需再干预的再通复发率为2.6%,将所有术后新发静脉曲张均计为复发则复发率近54%。
- 按初步定义(隐股交界区域或原治疗静脉远端走行区新发静脉曲张)临床相关复发率为5.3%。
- 新生血管为最大复发类型(隐股交界区域57.7%,远端9.9%),其次为再通(隐股交界区域8.9%,远端9.4%)和前副大隐静脉反流(7.5%)。
- 治疗静脉直径(P = .001)和CEAP临床分级(P = .008)是复发的显著预测因素。
关键数值与推荐
- 新复发分类包括方法失败(再通)、新生血管和疾病进展(未治疗静脉反流及治疗区域外新发静脉曲张)。
- 临床相关复发定义为隐股交界区域或原治疗静脉远端走行区新发静脉曲张。
临床怎么用
- 临床随访中应采用统一复发定义区分技术失败、疾病进展和真正复发,以指导再干预决策。
- 对治疗静脉直径较大或CEAP临床分级较高的患者,术后应加强超声监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although many studies have demonstrated that endovenous therapies have comparable efficacy to crossectomy and stripping, few studies have been published regarding the classification and recurrence patterns of varicose veins after endovenous therapy. This study attempted to provide an objective scheme for the definition and classification of recurrence. Moreover, it describes the types and rates of recurrence after endovenous thermal ablation, as well as factors associated with recurrence. METHODS: This prospective cohort study comprised a cohort of 449 patients with saphenofemoral junction (SFJ) insufficiency who underwent endoluminal varicose vein treatment for the first time in the limb between October 2013 and January 2015. The treatments were performed by a team of three experienced phlebologists. For endovenous laser ablation, Biolitec ELVeS was used with bare, radial or radial slim fibers. Radiofrequency ablation was performed with VNUS ClosureFAST (Medtronic, Deggendorf, Germany). The patients were consecutively scheduled for 3-year follow-up examinations. Detailed ultrasound findings were collected by two experienced phlebologists who classified the observed duplex ultrasound recurrence into different recurrence types. RESULTS: Clinically relevant recurrence was found in only 5.1% of cases. Examining only the recanalizations requiring reintervention resulted in a recurrence rate of 2.6%. However, if every new varicose vein that occurred postoperatively was considered a recurrence, the resultant recurrence rate was almost 54%. Preliminarily, we defined a recurrence as newly developed varicose veins within the region of the SFJ or along the course of the former treated vein distal to the SFJ. According to this definition, we obtained a clinically relevant recurrence rate of 5.3%, thus indicating that neovascular vessels were the largest recurrence type (57.7% within the region of the SFJ and 9.9% distal to the SFJ), followed by recanalization (8.9% within the region of the SFJ and 9.4% distal to the SFJ) and a refluxing anterior accessory saphenous vein (7.5%). We also developed a modified classification of progression to better understand recurrence after treatment of chronic venous insufficiency; the scheme included method failure (recanalization), neovascularizations, and disease progression (refluxing untreated vessels and new varicose veins occurring outside the treated region). The diameter of the treated vein (P = .001) and the clinical class according to CEAP classification (P = .008) were significant predictors of recurrence. CONCLUSIONS: Endoluminal therapies are efficient methods for the treatment of varicose veins, which result in low recurrence rates after 3 years. Several factors influence the development of recurrence. This study provides a practice-oriented classification and description of recurrence with clinical relevance, through making distinctions among technical error, progression of the underlying disease and actual recurrence.
引用
- Zollmann M, Zollmann C, Zollmann P, et al. Recurrence types 3 years after endovenous thermal ablation in insufficient saphenofemoral junctions. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32361003. doi:10.1016/j.jvsv.2020.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。